| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,795 | 19,248 | 20,102 | 21,055 | | Cost of Revenue | 2,670 | 2,777 | 2,892 | 2,864 | | | Gross Profit | 16,125 | 16,471 | 17,210 | 18,191 | | | Operating Expenses | | Research Development | 2,833 | 2,655 | 2,559 | 2,427 | | Selling General and Administrative | 8,197 | 10,671 | 9,944 | 8,957 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,095 | 3,145 | 4,707 | 6,807 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52 | 95 | 12 | 84 | | Earnings Before Interest And Taxes | 5,147 | 3,240 | 4,719 | 6,891 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 5,147 | 3,240 | 4,719 | 6,891 | | Income Tax Expense | 1,343 | 1,386 | 1,930 | 2,821 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,804 | 1,854 | 2,789 | 4,070 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,804 | 1,854 | 2,789 | 4,070 | | Preferred Stock And Other Adjustments | (84) | (71) |
-
|
-
| | | Net Income Applicable To Common Shares | $3,720 | $1,783 | $2,789 | $4,070 |
|
0.76% Nasdaq 
Income Statement
